Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Nicolas D et al.2015. Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4. Expert Rev Anti Infect Ther 13: 947–963.
-
2.
Proietti FA , Carneiro-Proietti AB , Catalan-Soares BC , Murphy EL , 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058–6068.
-
3.
Marinho J , Galvao-Castro B , Rodrigues LC , Barreto ML , 2005. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case–control study. J Acquir Immune Defic Syndr 40: 625–628.
-
4.
de Lourdes Bastos M et al.2009. Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis. Int J Tuberc Lung Dis 13: 1519–1523.
-
5.
Norrgren HR et al.2008. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 48: 607–610.
-
6.
Verdonck K et al.2007. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 11: 1066–1072.
-
7.
Verdonck K , Gonzalez E , Schrooten W , Vanham G , Gotuzzo E , 2008. HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru. Epidemiol Infect 136: 1076–1083.
-
8.
Seaton RA , 1997. Tuberculosis and human T-cell lymphotropic virus type 1 infection. https://doi.org/10.1093/clinids/24.5.1026.
-
9.
Grassi MF et al.2016. Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil. BMC Infect Dis 16: 491.
-
10.
Gessain A , Cassar O , 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3: 388.
-
11.
Eshima N et al.2009. Age and gender specific prevalence of HTLV-1. J Clin Virol 45: 135–138.
-
12.
Allain JP et al.1992. Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians. J Acquir Immune Defic Syndr 5: 1230–1236.
-
13.
Schierhout G et al.2020. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20: 133–143.
-
14.
Journo C , Mahieux R , 2011. HTLV-1 and innate immunity. Viruses 3: 1374–1394.
-
15.
Carvalho NB et al.2018. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. Tuberculosis (Edinb) 108: 35–40.
-
16.
Sia JK , Rengarajan J , 2019. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr 7: 10.
-
17.
Kohno T et al.2005. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 96: 527–533.
-
18.
Jasenosky LD , Scriba TJ , Hanekom WA , Goldfeld AE , 2015. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264: 74–87.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 6121 | 1449 | 22 |
| Full Text Views | 61 | 38 | 1 |
| PDF Downloads | 60 | 32 | 2 |
Prevalence of HTLV-I Infection and Its Association with Tuberculosis among Patients at an Urban Clinic in Haiti
Kathleen F. Walsh
Kathleen F. Walsh
Center for Global Health, Weill Cornell Medicine, New York, New York;
Division of General Internal Medicine, Weill Cornell Medicine, New York, New York;
Search for other papers by Kathleen F. Walsh in
Current site
Google Scholar
PubMed
Division of General Internal Medicine, Weill Cornell Medicine, New York, New York;
Search for other papers by Kathleen F. Walsh in
Current site
Google Scholar
PubMed
Myung Hee Lee
Myung Hee Lee
Center for Global Health, Weill Cornell Medicine, New York, New York;
Search for other papers by Myung Hee Lee in
Current site
Google Scholar
PubMed
Search for other papers by Myung Hee Lee in
Current site
Google Scholar
PubMed
Josef A. Brejt
Josef A. Brejt
Division of General Internal Medicine, Weill Cornell Medicine, New York, New York;
Search for other papers by Josef A. Brejt in
Current site
Google Scholar
PubMed
Search for other papers by Josef A. Brejt in
Current site
Google Scholar
PubMed
Mary J. Reust
Mary J. Reust
Center for Global Health, Weill Cornell Medicine, New York, New York;
Search for other papers by Mary J. Reust in
Current site
Google Scholar
PubMed
Search for other papers by Mary J. Reust in
Current site
Google Scholar
PubMed
Marc Jean Juste
Marc Jean Juste
GHESKIO Centers, Port-au-Prince, Haiti;
Search for other papers by Marc Jean Juste in
Current site
Google Scholar
PubMed
Search for other papers by Marc Jean Juste in
Current site
Google Scholar
PubMed
Genevieve Hilaire
Genevieve Hilaire
GHESKIO Centers, Port-au-Prince, Haiti;
Search for other papers by Genevieve Hilaire in
Current site
Google Scholar
PubMed
Search for other papers by Genevieve Hilaire in
Current site
Google Scholar
PubMed
Jean William Pape
Jean William Pape
Center for Global Health, Weill Cornell Medicine, New York, New York;
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York;
GHESKIO Centers, Port-au-Prince, Haiti;
Search for other papers by Jean William Pape in
Current site
Google Scholar
PubMed
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York;
GHESKIO Centers, Port-au-Prince, Haiti;
Search for other papers by Jean William Pape in
Current site
Google Scholar
PubMed
Serena Koenig
Serena Koenig
Brigham and Women’s Hospital, Boston, Massachusetts
Search for other papers by Serena Koenig in
Current site
Google Scholar
PubMed
Search for other papers by Serena Koenig in
Current site
Google Scholar
PubMed
Kathryn Dupnik
Kathryn Dupnik
Center for Global Health, Weill Cornell Medicine, New York, New York;
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York;
Search for other papers by Kathryn Dupnik in
Current site
Google Scholar
PubMed
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York;
Search for other papers by Kathryn Dupnik in
Current site
Google Scholar
PubMed
ABSTRACT.
This retrospective case–control study examined the prevalence of HTLV-I and its association with tuberculosis among urban clinic patients in Haiti. Prevalence of HTLV-I among tuberculosis cases was 2.1% and among controls was 2.4%. Prevalence of HLTV-I was higher in females than males (odds ratio [OR] 2.45, P = 0.020). HTLV-I prevalence in those ≥ 50 years was 8.4% compared with 1.3% in those < 50 (OR 6.74, P < 0.001). We found no association between HTLV-I and tuberculosis in this population.
Author Notes
Financial support: This work was supported by the National Institutes of Health grants K23-AI131913 (to K. M. D.), and U19-AI111143.
Authors’ addresses: Kathleen F. Walsh, Myung Hee Lee, Josef A. Brejt, Mary J. Reust, and Kathryn Dupnik, Weill Cornell Medicine, New York, NY, E-mails: kfw2001@med.cornell.edu, myl2003@med.cornell.edu, jab9179@med.cornell.edu, juliet319@gmail.com, and kd9040@med.cornell.edu. Marc Jean Juste, Genevieve Hilaire and Jean William Pape, GHESKIO Centers, Port-au-Prince, Haiti, E-mails: mjeanjuste@gheskio.org, gehissah@gmail.com, and jwpape@gheskio.org. Serena Koenig, Brigham and Women’s Hospital, Boston, MA, E-mail: skoenig@bwh.harvard.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Nicolas D et al.2015. Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4. Expert Rev Anti Infect Ther 13: 947–963.
-
2.
Proietti FA , Carneiro-Proietti AB , Catalan-Soares BC , Murphy EL , 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058–6068.
-
3.
Marinho J , Galvao-Castro B , Rodrigues LC , Barreto ML , 2005. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case–control study. J Acquir Immune Defic Syndr 40: 625–628.
-
4.
de Lourdes Bastos M et al.2009. Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis. Int J Tuberc Lung Dis 13: 1519–1523.
-
5.
Norrgren HR et al.2008. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 48: 607–610.
-
6.
Verdonck K et al.2007. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 11: 1066–1072.
-
7.
Verdonck K , Gonzalez E , Schrooten W , Vanham G , Gotuzzo E , 2008. HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru. Epidemiol Infect 136: 1076–1083.
-
8.
Seaton RA , 1997. Tuberculosis and human T-cell lymphotropic virus type 1 infection. https://doi.org/10.1093/clinids/24.5.1026.
-
9.
Grassi MF et al.2016. Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil. BMC Infect Dis 16: 491.
-
10.
Gessain A , Cassar O , 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3: 388.
-
11.
Eshima N et al.2009. Age and gender specific prevalence of HTLV-1. J Clin Virol 45: 135–138.
-
12.
Allain JP et al.1992. Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians. J Acquir Immune Defic Syndr 5: 1230–1236.
-
13.
Schierhout G et al.2020. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20: 133–143.
-
14.
Journo C , Mahieux R , 2011. HTLV-1 and innate immunity. Viruses 3: 1374–1394.
-
15.
Carvalho NB et al.2018. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. Tuberculosis (Edinb) 108: 35–40.
-
16.
Sia JK , Rengarajan J , 2019. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr 7: 10.
-
17.
Kohno T et al.2005. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 96: 527–533.
-
18.
Jasenosky LD , Scriba TJ , Hanekom WA , Goldfeld AE , 2015. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264: 74–87.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 6121 | 1449 | 22 |
| Full Text Views | 61 | 38 | 1 |
| PDF Downloads | 60 | 32 | 2 |